Skip to main content
. 2021 Jun 29;11:13471. doi: 10.1038/s41598-021-92860-2

Figure 3.

Figure 3

Cucurbitacin B, gossypol, and obatoclax induced EV secretion in a variety of cells. (ac) HEK293T cells were treated with 1 μM amlodipine, 0.3 μM osimertinib, 1 μM cucurbitacin B, 1 μM doramectin, 0.3 μM gossypol, 10 μM HA14-1, 10 μM miltefosine, or 0.03 μM obatoclax for 24 h and then secreted EVs were determined using a TIM4-CD63 ELISA (a), TIM4-CD9, TIM4-CD63, TIM4-CD81 ELISA (b) or NTA (c). (d) Cell lines were treated with cucurbitacin B, gossypol, or obatoclax at the concentrations shown on Table 3 for 24 h, and then secreted EVs were determined using a TIM4-ELISA. EVs secreted from hMSC, K562, HCT116, SW480, SW620, and NIH/3T3 cells were detected using TIM4-CD63 ELISA. EVs secreted from THP-1, EL4, and Jurkat cells were detected using TIM4-CD81 ELISA. *p < 0.05, **p < 0.01, versus DMSO, Student’s t-test.